Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00588107 · ClinicalTrials.gov registry record · NA

A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors

A NA study of Cancer, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
374
Enrollment target
1
Study location

NCT00588107 is a NA study of Cancer that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 374 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00588107, a NA study of Cancer, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
374 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to compare two different ways of helping people who have had childhood cancer, leukemia, tumors or similar illnesses learn health information and information about trying to quit smoking. All participants received materials in the mail about their health, survivorship, and smoking. Some participants were also invited to use a website. The goal of the study was to see which is a better way to get information about health issues, survivorship, and smoking.

Conditions Studied

Interventions

  • OTHER Web Intervention
  • BEHAVIORAL print materials

Study Locations (1)

Massachusetts

  • DFCI - Boston

Trial Details

FieldValue
Enrollment Target 374 participants
Start Date 2005-09
Est. Completion 2013-12
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT00588107

The ClinicalTrials.gov registry entry for NCT00588107 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 374 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Web Intervention is the first listed.

NCT00588107 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00588107 about?

NCT00588107 is a clinical study titled "A Web Site and Print Materials Intervention for Smoking Intervention for Childhood and Young Adult Cancer Survivors". The purpose of this study was to compare two different ways of helping people who have had childhood cancer, leukemia, tumors or similar illnesses learn health information and information about trying to quit smoking. All participants received materials in the mail about their health, survivorship, ...

What is the current status of trial NCT00588107?

This trial is currently completed. It is a NA study. The enrollment target is 374 participants. The study started on 2005-09. Estimated completion is 2013-12.

What conditions does trial NCT00588107 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT00588107?

The interventions under investigation include: Web Intervention (OTHER), print materials (BEHAVIORAL).

Who is sponsoring clinical trial NCT00588107?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00588107 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.